Literature DB >> 3422539

Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome.

D B Stoll1, P Peterson, R Exten, J Laszlo, A V Pisciotta, J T Ellis, P White, K Vaidya, M Bozdech, S Murphy.   

Abstract

Six women presented with the clinical picture of essential thrombocythemia (ET) without the anemia, marked splenomegaly, and extreme leukocytosis characteristic of chronic myelogenous leukemia (CML). All had the Philadelphia chromosome on karyotype analysis of the bone marrow. Peripheral basophilia was present in four cases, providing a clinical clue that the Philadelphia chromosome might be present. Marrow biopsy showed granulocytic hyperplasia and either small megakaryocytes or sheets of megakaryocytes with marked atypia, findings that are more typical of CML than ET. The clinical importance of finding the Philadelphia chromosome in patients who seem to have ET is in assessing prognosis. ET generally follows a chronic, indolent course. However, five of these six patients who had the Philadelphia chromosome underwent clinical transition to the accelerated phase of CML or blastic leukemia in 4-7 years.

Entities:  

Mesh:

Year:  1988        PMID: 3422539     DOI: 10.1002/ajh.2830270202

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow.

Authors:  Young Jae Byun; Byeong-Bae Park; Eun Sung Lee; Kyung Soo Choi; Dae Sung Lee
Journal:  Blood Res       Date:  2014-06-25

Review 2.  Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015.

Authors:  Philip A Thompson; Hagop M Kantarjian; Jorge E Cortes
Journal:  Mayo Clin Proc       Date:  2015-10       Impact factor: 7.616

Review 3.  Routine and specialised techniques in the diagnosis of haematological neoplasms.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

4.  Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.

Authors:  Gholamreza Toogeh; Shirin Ferdowsi; Fatemeh Naadali; Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Reza Shirkoohi; Seyed H Ghaffari
Journal:  Med Oncol       Date:  2010-05-25       Impact factor: 3.064

5.  Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate.

Authors:  Yoo Jin Lee; Joon Ho Moon; Ho Cheol Shin; Jong Won Seo; Seo Ae Han; Sang Kyeong Seo; Sang Kyun Sohn
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

Review 6.  Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.

Authors:  Ayalew Tefferi; Radek Skoda; James W Vardiman
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

7.  Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors.

Authors:  Zhihe Liu; Hongqiong Fan; Yuying Li; Chunshui Liu
Journal:  Onco Targets Ther       Date:  2017-07-17       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.